Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components

Details for Australian Patent Application No. 2004212703 (hide)

International Classifications

Event Publications

11 August 2005 PCT application entered the National Phase

PCT publication WO2004/073728 Priority application(s): WO2004/073728

30 October 2008 Application Accepted

Published as AU-B-2004212703

27 November 2008 Application for Amendment

The nature of the amendment is: Amend the name of the co-inventor to read from GorczynskiI, Reginald to Gorczynski, Reginald. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

22 January 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 24 Dec 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

26 March 2009 Amendment Made

The nature of the amendment is: Amend the name of the co-inventor to read from Gorczynskil, Reginald to Gorczynski, Reginald

21 May 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 24 Dec 2008

21 May 2009 Standard Patent Sealed

15 September 2011 Assignment Registered

Clinique La Prairie Research SA The patent has been assigned to Clinique La Prairie Franchising S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.